These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30365680)

  • 1. Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.
    Izar MCO; Fonseca FAH
    Arq Bras Cardiol; 2018 Oct; 111(4):585-586. PubMed ID: 30365680
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
    Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC
    Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
    Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
    Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

  • 7. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

  • 10. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
    Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Hypercholesterolemia: A Reportable Disorder.
    Kullo IJ
    Circulation; 2020 Nov; 142(21):1999-2001. PubMed ID: 33226870
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
    Andersen R; Andersen L
    J Clin Lipidol; 2016; 10(2):225-7. PubMed ID: 27055953
    [No Abstract]   [Full Text] [Related]  

  • 17. Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Hopkins PN
    Curr Opin Lipidol; 2017 Apr; 28(2):136-143. PubMed ID: 28030379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward.
    Santos RD; Frauches TS; Chacra AP
    J Atheroscler Thromb; 2015; 22(9):869-80. PubMed ID: 26194978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: a longitudinal study among participants.
    van Maarle MC; Stouthard ME; Bonsel GJ
    J Med Genet; 2003 Jan; 40(1):e3. PubMed ID: 12525551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.